Analytical Data
-
基因名
CSPG5
- Application
-
别名
NGC; CALEB; Acidic leucine-rich EGF-like domain-containing brain protein; Neuroglycan C
-
种属
Rat
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9ERQ6
-
表达区间
Ala139~Arg370
-
分子量
41kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CSPG5, or Chondroitin Sulfate Proteoglycan 5, is a member of the chondroitin sulfate proteoglycan family, which plays crucial roles in cell signaling, tissue development, and the modulation of the extracellular matrix. CSPG5 is primarily expressed in the brain and has been implicated in various neurological conditions, as well as in the regulation of cell behavior during development and injury response. Research into CSPG5 has gained momentum due to its involvement in processes such as neuroinflammation, which contributes to conditions like Alzheimer's disease and multiple sclerosis. Moreover, CSPG5 has been suggested to influence tumor progression and metastasis in certain cancers. The recombinant protein form of CSPG5 allows for detailed studies of its structure-function relationships, interactions with other biomolecules, and its potential therapeutic applications. Investigating CSPG5 at the molecular level can provide insights into its precise role in cellular mechanisms and may unveil novel strategies for treating neurological disorders and cancer. Thus, producing CSPG5 as a recombinant protein is crucial for advancing our understanding of its biology and exploring its potential as a biomarker or therapeutic target in various diseases.
